Osteonectin Human Recombinant fused with 6X His tag produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 295 amino acids and having a molecular mass of 34 kDa.
SPARC is expressed with a 6 amino acid His tag at N-Terminus and purified by proprietary chromatographic techniques.
SPARC is a 40 kDa protein consisting of a single polypeptide chain that can be divided into four distinct domains :
These domains enable SPARC to interact with various components of the ECM, including collagen and hydroxyapatite, facilitating its role in bone mineralization and cell-matrix interactions .
SPARC is involved in several biological processes, including:
SPARC is predominantly expressed in non-epithelial cells, including endothelial and smooth muscle cells, osteoblasts, and platelets . Its expression is regulated by various factors, including retinoic acid and dexamethasone, which can stimulate SPARC transcription through specific promoter elements .
Overexpression of SPARC has been associated with several types of cancer, including breast, prostate, colon, and pancreatic cancers . Its role in promoting angiogenesis and cell migration makes it a potential target for cancer therapy . Additionally, SPARC is involved in wound healing and tissue remodeling, making it a critical protein for maintaining tissue homeostasis .
Recombinant SPARC proteins, such as the human recombinant SPARC with a His tag, are produced using recombinant DNA technology. These proteins are used in various research applications to study the functions and interactions of SPARC in vitro. The His tag facilitates the purification and detection of the recombinant protein, making it a valuable tool for biochemical and structural studies .